Valuation (31%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 94.39 | 1.33 |
PEG Ratio (TTM) | -2.25 | 4.04 |
P/S Ratio (TTM) | 1.77 | 1.43 |
P/B Ratio (TTM) | 2.53 | 5.36 |
P/FCF Ratio (TTM) | 19.13 | 5.00 |
Price to 5YR AVG Earnings Ratio | N/A | 26.00 |
Price to 5YR AVG FCF Ratio | N/A | 20.48 |
Profitability (15%) |
Company | Industry |
---|---|---|
ROA (TTM) | 2.00% | 5.48% |
ROE (TTM) | 2.76% | 7.97% |
Net Profit Margin (TTM) | 1.98% | 5.24% |
ROIC 5YR AVG | N/A | 14.19% |
Growth (35%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -75.04% | 2,905.24% | N/A |
Revenue | 0.56% | 72.72% | N/A |
Net Income | -75.21% | 2,933.82% | N/A |
Cash Flow | -6.58% | 95.10% | N/A |
Health (53%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 4.58 | 2.01 |
Quick Ratio (TTM) | 3.28 | 1.21 |
D/E Ratio (TTM) | N/A | 2.10 |
Interest Coverage (TTM) | 0.97 | 12.05 |
Piotroski F-Score | 5 | 7 |
Altman Z-Score | 6.28 | 3.66 |
LTL to 5YR AVG FCF | N/A | 5.60 |
Shares Outstanding Growth 5YR AVG | N/A | -0.55% |